logo

VRTX

Vertex PharmaceuticalsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

VRTX Profile

Vertex Pharmaceuticals Incorporated

A company that develops therapies for the treatment of cystic fibrosis

Biological Technology
--
07/24/1991
NASDAQ Stock Exchange
6,100
12-31
Common stock
50 Northern Avenue, Boston, Massachusetts 02210
Develop and create transformative drugs
Founded in 1989, Vertex Pharmaceuticals Incorporated is a global biotechnology company. The company is dedicated to the discovery, development, production and commercialization of small molecule drugs for serious diseases in the professional market. The company has partnerships with some of the world's largest pharmaceutical companies, leading non-profit disease research institutions, and many of the world's most renowned academic institutions. The company has two products: KALYDECO and INCIVEK.